COMPOSICION FARMACEUTICA INTRAMUSCULAR O SUBCUTANEA QUE COMPRENDE TMC278 (RILPIVIRINA); PROCESO PARA PREPARAR LA COMPOSICION; Y USO PARA EL TRATAMIENTO O PREVENCION DE INFECCION POR VIH

COMPOSICION FARMACEUTICA INTRAMUSCULAR O SUBCUTANEA QUE COMPRENDE TMC278 (RILPIVIRINA); PROCESO PARA PREPARAR LA COMPOSICION; Y USO PARA EL TRATAMIENTO O PREVENCION DE INFECCION POR VIH

This invention concerns pharmaceutical compositions for administration via intramuscular or subcutaneous injection, comprising micro- or nanoparticles of the NNRTI compound TMC278, suspended in an aqueous pharmaceutically acceptable carrier, and the use of such pharmaceutical compositions in the tre...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
1. Verfasser: BAERT LIEVEN ELVIRE COLETTE,DRIES WILLY ALBERT MARIA CARLO,SCHUELLER LAURENT BRUNO,FRANCOIS MARC KAREL JOZEF,VAN REMOORT
Format: Patent
Sprache:spa
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This invention concerns pharmaceutical compositions for administration via intramuscular or subcutaneous injection, comprising micro- or nanoparticles of the NNRTI compound TMC278, suspended in an aqueous pharmaceutically acceptable carrier, and the use of such pharmaceutical compositions in the treatment and prophylaxis of HIV infection.